@article{article, title  = {{The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer}},

 publisher = {{Informa UK Limited}},

 url = {{https://doi.org/10.1186/s40545-023-00529-0 }},

 year = {{2024}},

 month = {{3}},

 author = {{Sharman Moser S and Tanser F and Siegelmann-Danieli N and Apter L and Chodick G and Solomon J}},

 doi = {{10.1186/s40545-023-00529-0}},

 volume = {{16}},

 journal = {{Journal of Pharmaceutical Policy and Practice}},

 issue = {{1}},

 pages = {{22}},

 note = {{Accessed on 2025/02/05}}}